Daniel from Improve Press
AI-driven dermatology platform Cureskin has netted $20 million in a Sequence B funding spherical led by HealthQuad. The spherical was additionally participated by JSW Ventures, Khosla Ventures, and Sharrp Ventures.
“These funds will assist additional improve our AI capabilities, speed up our development, and increase answer choices,” mentioned co-founder and CEO Guna Kakulapati in a press release.
Cureskin beforehand raised $5 million in Sequence A funding. Thus far, it claims to have handled about 1.5 million clients for varied pores and skin circumstances by way of its app. It notes that over 80% of them are from tier 2 and three cities.
Diabetes-focused well being tech startup Sugar.match has acquired a further $5 million in Sequence A funding from B Capital.
This brings its complete Sequence A funding, the primary spherical of which occurred in November, to $16 million.
In a press release, the corporate mentioned it’ll use its extra funds to increase its choices, improve its presence, and hasten R&D in diabetes administration.
Since launching by end-2021, Sugar.match has now served over 30,000 customers on its platform, providing a personalised, complete program for managing diabetes that leverages steady glucose monitoring expertise and knowledge. It has additionally lately began working diabetes clinics in Bangalore, which provide a variety of providers similar to stress therapies, stay health and yoga classes, and VR chromotherapy.
Diagnostic service supplier Cardiotrack, a model of Uber Diagnostics, has obtained $2 million in a pre-Sequence A funding spherical led by Girish Narasimhan, angel investor and principal of a world funding banking agency.
This provides to the $1.6 million it raised beforehand from a cohort of high-net-worth people. It has not disclosed the place and the way it will use its recent funds.
Cardiotrack, which gives telemedicine kits, medical-grade and IoT diagnostic units, and knowledge analytics options, serves a few of India’s largest well being and life insurers and community of diagnostic centres in over 300 places.
